The Chondroplasty Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Chondroplasty Market:
https://www.thebusinessresearchcompany.com/report/chondroplasty-global-market-report
According to The Business Research Company’s Chondroplasty Global Market Report 2024, The chondroplasty market size has grown strongly in recent years. It will grow from $12.92 billion in 2023 to $13.77 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased sports-related injuries, patient preference for non-total joint replacement, postoperative care advances, healthcare provider training and expertise, increasing incidence of joint disorders..
The chondroplasty market size is expected to see strong growth in the next few years. It will grow to $17.29 billion in 2028 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to regenerative medicine integration, focus on outpatient procedures, introduction of novel biomaterials, rise in musculoskeletal disorders, expansion of geriatric population.. Major trends in the forecast period include technological integration in rehabilitation, arthroscopic techniques, cartilage repair and regeneration, technological innovations in surgical tools, integration of navigation systems..
The rising incidence of joint-related disorders is expected to propel the growth of the chondroplasty market going forward. Joint disorders are diseases that affect the health and function of a joint caused by overuse of a joint or a sudden injury, such as an accident or a sports injury. Chondroplasty treats joint-related disorders by repairing the damaged cartilage in a joint. For instance, in August 2023, according to the data published by The Lancet, a UK-based book and periodic data publishing organization, the incidence of gout, an inflammatory arthritis affecting joints, rose from 1.40 diagnoses per 1,000 adults in March 2021 to 1.44 diagnoses per 1,000 adults in March 2022 in the UK. Further, in June 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, it is estimated that 78.4 million (25.9%) US adults aged 18 years or older are expected to have doctor-diagnosed arthritis (BRFSS) by 2040. Therefore, the rising incidence of joint-related disorders is driving the growth of the chondroplasty market going forward.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13185&type=smp
The chondroplasty market covered in this report is segmented –
1) By Type: Radiofrequency Ablation Chondroplasty, Abrasion Chondroplasty, Atellar Chondroplasty, Meniscal Repair, Tissue Removal, Other Types
2) By Anatomy: Knee, Shoulder, Hip, Other Anatomies
3) By Equipment: Shavers, Radiofrequency Devices, Arthroscope, Other Equipments
4) By End Use: Hospitals, Orthopedic Clinics, Academic Research, Other End Uses
Major companies operating in the chondroplasty market are developing innovative technologies, such as articular cartilage segmentation tools, to provide reliable customer service. An articular cartilage segmentation tool is a software application that automatically or semi-automatically segments articular cartilage from magnetic resonance imaging (MRI) scans. For instance, in July 2021, RSIP Vision, an Israel-based field-tested software solution, launched the Articular Cartilage Segmentation Tool that delivers an accurate, non-invasive, and automatic assessment of chondral lesions and cartilage-sparing procedures (mosaicplasty, micro-fracture, chondroplasty/osteochondral autograft transfer system, autologous chondrocyte implantation) using deep learning algorithms to segment cartilage from MRI scans automatically. Doctors can more accurately assess an athlete’s cartilage integrity and offer the best cartilage-sparing treatment using the RSIP Vision module, resulting in better outcomes and shorter recovery times.
The chondroplasty market report table of contents includes:
1. Executive Summary
2. Chondroplasty Market Characteristics
3.Chondroplasty Market Trends And Strategies
4. Chondroplasty Market analysis
5. Chondroplasty Market Size And Growth
6. Chondroplasty Segmentation
7. Chondroplasty Regional And Country Analysis
.
.
.
27.Chondroplasty Competitive Landscape And Company Profiles
28.Chondroplasty Key Mergers And Acquisitions
29.Chondroplasty Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Johnson & Johnso
- F. Hoffmann-La Roche Ltd.
- Osiris Therapeutics Inc.
- Thermo Fisher Scientific Inc.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
